Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It Is Not Only About Price!

BioDrugs - United Kingdom
doi 10.1007/s40259-019-00395-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy